肝癌患者凝血四项指标联合检测剖析.docVIP

肝癌患者凝血四项指标联合检测剖析 　　[摘要] 目的 分析肝癌凝血4项指标联合检测的意义。方法 选择2015年2―10月该院肝癌患者30例，另纳入同期健康人30例。对比凝血4项检测结果。 结果 肝癌患者FBG为（2.6±0.3）g/L，显著低于健康对照组，PT时间为（20.5±1.6）s，APTT为（42.3±1.5）s，TT为（18.1±0.5）s，显著高于对照组（P0.05）。凝血4项指标检出阳性率分别为30.00%（20/60），26.67%（18/60），46.67%（28/60），23.33%（16/60），显著高于对照组（P0.05）。 结论 重视对肝癌患者凝血4项的联合检测可对凝血状况、肝脏受损程度作出准确分析。 　　[关键词] 肝癌；凝血四项；联合检测 　　[中图分类号] R735.7 [文献标识码] A [文章编号] 1674-0742（2016）05（b）-0059-02 　　[Abstract] Objective To analyze the significance of combined detection of four blood coagulation indexes in patients with liver cancer. Methods 30 cases of patients with liver cancer treated in our hospital from February 2015 to October 2015 were selected， and 30 healthy people treated at the same period were selected， and the detection results of four blood coagulation indexes were compared. Results The FBG of patients with liver cancer was（2.6±0.3） g/L， which was obviously lower than that of the control group， the PT time， APTT and TT of the patients with liver cancer were respectively （20.5±1.6） s， （42.3±1.5） s and （18.1±0.5） s， which were obviously higher than those in the control group（P0.05）， the detection positive rates of four blood coagulation indexes of the patients with liver cancer were respectively 30.00% （20/60）， 26.67% （18/60）， 46.67% （28/60） and 23.33% （16/60）， which were obviously higher than those of the control group（P0.05）. Conclusion It can accurately analyze the blood coagulation condition and liver damage degree to pay attention to the combined detection of four blood coagulation indexes in patients with liver cancer. 　　[Key words] Liver cancer； Four blood coagulation indexes； Combined detection 　　肝癌为肝脏相关重症疾病之一，具有恶性程度高，进展速度快，侵袭性强的特点[1-2]。有关报道中指出[3-5]：肝癌患者在肝功能受损症状影响下，凝血因子合成大量减少，进而可能诱发凝血功能障碍。该研究以2015年2―10月为研究期间，方便选择该院收治原发性肝癌患者60例以及健康体检者60例作为研究对象，就两组受检对象在凝血4项检出值、检出阳性率方面的情况展开对照分析，以探讨凝血四项指标联合检测对肝癌诊断的价值，现报道如下。 　　1 资料与方法 　　1.1 一般资料 　　该研究中选择该院所收治原发性肝癌患者作为研究对象，共60例，设置为肝癌组。另纳入同期经体检中心健康检查排除肝癌病变的健康体检者60例作为对照对象。研究内容经过伦理委员会批准，所有研究对象均对研究内容知情同意，签署知情同意书。